-
-
-
-
-
-
-
Mirum and Incyte to present zilurgisertib study results at ENDO 2026
-
-
-
-
-
-
-
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
-
-
-
-
-
-
-
Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA'
-
-
-
-
-
-
-
Celcuity reports positive Phase 3 trial results for gedatolisib in breast cancer
-
-
-
-
-
-
-
Vera Therapeutics moves up atacicept analysis timeline with FDA agreement
-
-
-
-
-
-
-
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
-
-
-
-
-
-
-
Cogent (COGT) Reiterated at Buy by Stifel After ASCO Presentation on Bezuclastinib
-
15,439 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

